Literature DB >> 24577531

Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.

M M Imanguli1, E W Cowen2, J Rose3, S Dhamala3, W Swaim4, S Lafond3, B Yagi3, R E Gress3, S Z Pavletic3, F T Hakim3.   

Abstract

Activation and migration of regulatory T cells (Treg) into tissue is critical in control of inflammation, but has not been examined extensively in chronic graft versus host disease (cGVHD). In parallel studies of tissues and blood, we determined that FoxP3(+) T cells increased in proportion to T effectors (Teff) in tissue infiltrates in oral and cutaneous lichenoid cGVHD. These FoxP3(+) cells expressed distinguishing phenotypic and functional markers of Treg (CD3(+), CD4(+), CD27(+), ICOS(+) and CD39(+)), not found on FoxP3(-) Teff. Both Teff and FoxP3(+) Treg expressed T-bet and the chemokine receptor CXCR3, however, consistent with a common mechanism of chemokine-mediated migration into tissue. Furthermore, functional markers (ICOS and CD39) and chemokine receptors (CXCR3) were both present in a higher proportion of FoxP3(+) cells in tissues than in peripheral blood, consistent with recruitment and activation of Treg in cGVHD target tissues. Finally, the 'activated' CD45RA(-)FoxP3(hi) subset of Treg cells, which highly express functional markers, were found in comparable frequencies in cGVHD patients and normal controls, despite a significant deficit in naive 'resting' Treg. These findings are consistent with Treg capacity to upregulate functional markers and traffick into tissue in cGVHD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577531      PMCID: PMC7670308          DOI: 10.1038/leu.2014.92

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  47 in total

1.  Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation.

Authors:  Kirsten M L Hertoghs; Perry D Moerland; Amber van Stijn; Ester B M Remmerswaal; Sila L Yong; Pablo J E J van de Berg; S Marieke van Ham; Frank Baas; Ineke J M ten Berge; René A W van Lier
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD.

Authors:  Joanne E Croudace; Charlotte F Inman; Ben E Abbotts; Sandeep Nagra; Jane Nunnick; Prem Mahendra; Charles Craddock; Ram Malladi; Paul A H Moss
Journal:  Blood       Date:  2012-09-25       Impact factor: 22.113

3.  Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

Authors:  Kathrin Rieger; Christoph Loddenkemper; Jochem Maul; Thomas Fietz; Daniel Wolff; Harald Terpe; Beate Steiner; Erika Berg; Stephan Miehlke; Martin Bornhäuser; Thomas Schneider; Martin Zeitz; Harald Stein; Eckhard Thiel; Rainer Duchmann; Lutz Uharek
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

4.  Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome.

Authors:  O Bestard; L Cuñetti; J M Cruzado; M Lucia; R Valdez; S Olek; E Melilli; J Torras; R Mast; M Gomà; M Franquesa; J M Grinyó
Journal:  Am J Transplant       Date:  2011-07-12       Impact factor: 8.086

5.  Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation.

Authors:  K Weinberg; B R Blazar; J E Wagner; E Agura; B J Hill; M Smogorzewska; R A Koup; M R Betts; R H Collins; D C Douek
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

6.  DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.

Authors:  Udo Baron; Stefan Floess; Georg Wieczorek; Katrin Baumann; Andreas Grützkau; Jun Dong; Andreas Thiel; Tina J Boeld; Petra Hoffmann; Matthias Edinger; Ivana Türbachova; Alf Hamann; Sven Olek; Jochen Huehn
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

Review 7.  Advances in graft-versus-host disease biology and therapy.

Authors:  Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Nat Rev Immunol       Date:  2012-05-11       Impact factor: 53.106

8.  Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.

Authors:  Pervinder Sagoo; Niwa Ali; Garima Garg; Frank O Nestle; Robert I Lechler; Giovanna Lombardi
Journal:  Sci Transl Med       Date:  2011-05-18       Impact factor: 17.956

9.  FOXP3 defines regulatory T cells in human tumor and autoimmune disease.

Authors:  Ilona Kryczek; Rebecca Liu; Guobin Wang; Ke Wu; Xiaogong Shu; Wojciech Szeliga; Linhua Vatan; Emily Finlayson; Emina Huang; Diane Simeone; Bruce Redman; Theodore H Welling; Alfred Chang; Weiping Zou
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

10.  T-bet is required for optimal proinflammatory CD4+ T-cell trafficking.

Authors:  Graham M Lord; Ravi M Rao; Hyeryun Choe; Brandon M Sullivan; Andrew H Lichtman; F William Luscinskas; Laurie H Glimcher
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

View more
  23 in total

Review 1.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

2.  Inducible costimulatory molecule deficiency induced imbalance of Treg and Th17/Th2 delays rejection reaction in mice undergoing allogeneic tracheal transplantation.

Authors:  Jingsong Xu; Yu Wu; Guifang Wang; Yanghua Qin; Li Zhu; Gusheng Tang; Qian Shen
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

3.  In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease.

Authors:  Nataliya P Buxbaum; Donald E Farthing; Natella Maglakelidze; Martin Lizak; Hellmut Merkle; Andrea C Carpenter; Brittany U Oliver; Veena Kapoor; Ehydel Castro; Gregory A Swan; Liliane M Dos Santos; Nicolas J Bouladoux; Catherine V Bare; Francis A Flomerfelt; Michael A Eckhaus; William G Telford; Yasmine Belkaid; Remy J Bosselut; Ronald E Gress
Journal:  JCI Insight       Date:  2017-06-15

4.  Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease.

Authors:  Amritha Balakrishnan; Nicholas Gloude; Roman Sasik; Edward D Ball; Gerald P Morris
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-24       Impact factor: 5.742

5.  T cell receptor repertoires after adoptive transfer of expanded allogeneic regulatory T cells.

Authors:  A Theil; C Wilhelm; M Kuhn; A Petzold; S Tuve; U Oelschlägel; A Dahl; M Bornhäuser; E Bonifacio; A Eugster
Journal:  Clin Exp Immunol       Date:  2016-11-27       Impact factor: 4.330

6.  Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study.

Authors:  Xiang-Yu Zhao; Xiao-Su Zhao; Yu-Tong Wang; Yu-Hong Chen; Lan-Ping Xu; Xiao-Hui Zhang; Wei Han; Huan Chen; Yu Wang; Chen-Hua Yan; Feng-Rong Wang; Jing-Zhi Wang; Kai-Yan Liu; Ying-Jun Chang; Xiao-Jun Huang
Journal:  Oncoimmunology       Date:  2016-10-28       Impact factor: 8.110

7.  Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.

Authors:  Frances T Hakim; Sarfraz Memon; Ping Jin; Matin M Imanguli; Huan Wang; Najibah Rehman; Xiao-Yi Yan; Jeremy Rose; Jacqueline W Mays; Susan Dhamala; Veena Kapoor; William Telford; John Dickinson; Sean Davis; David Halverson; Haley B Naik; Kristin Baird; Daniel Fowler; David Stroncek; Edward W Cowen; Steven Z Pavletic; Ronald E Gress
Journal:  J Immunol       Date:  2016-09-30       Impact factor: 5.422

8.  A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.

Authors:  Alex F Herrera; Haesook T Kim; Bhavjot Bindra; Kyle T Jones; Edwin P Alyea; Philippe Armand; Corey S Cutler; Vincent T Ho; Sarah Nikiforow; Bruce R Blazar; Jerome Ritz; Joseph H Antin; Robert J Soiffer; John Koreth
Journal:  Biol Blood Marrow Transplant       Date:  2014-07-10       Impact factor: 5.742

9.  Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.

Authors:  P Sakthivel; J Grunewald; A Eklund; D Bruder; J Wahlström
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

10.  Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study.

Authors:  Acf Motta; Q Zhan; A Larson; M Lerman; S-B Woo; R J Soiffer; G F Murphy; N S Treister
Journal:  Oral Dis       Date:  2018-03-13       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.